Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Jochanan Benbassat. (2024) Estimates of the lead time in screening for bladder cancer. Urologic Oncology: Seminars and Original Investigations 42:4, pages 110-114.
Crossref
Crossref
Claudia Schmitz-Dräger, Peter J. Goebell, Ellen Paxinos, Ekkehardt Bismarck, Jack Chen, Priya Balakrishnan, Michael Bates, Thomas Ebert, Bernd J. Schmitz-Dräger & Natalya Benderska-Söder. (2024) Potential of an mRNA-Based Urine Assay (Xpert® Bladder Cancer Detection1) in Hematuria Patients - Results from a Cohort Study. Bladder Cancer 10:1, pages 25-33.
Crossref
Crossref
Rasmus Søgaard Hansen, Signe Hedengran Biørn, Johan Baden Birk‐Korch, Søren Paludan Sheikh, Mads Hvid Poulsen & Pernille Just Vinholt. (2023) Prevalence of prostate cancer in men with haematuria: a systematic review and meta‐analysis. BJU International 131:5, pages 530-539.
Crossref
Crossref
Niyati Lobo, Luca Afferi, Marco Moschini, Hugh Mostafid, Sima Porten, Sarah P. Psutka, Shilpa Gupta, Angela B. Smith, Stephen B. Williams & Yair Lotan. (2022) Epidemiology, Screening, and Prevention of Bladder Cancer. European Urology Oncology 5:6, pages 628-639.
Crossref
Crossref
Eva Charlotte Kuckuck, Jörg Hennenlotter, Tilman Todenhöfer, Lenuta-Ancuta Brünn, Georg-Christian Rass, Arnulf Stenzl, Oliver W. Hakenberg, Florian Roghmann, Peter J. Goebell, Marc-Oliver Grimm, Armin Pycha, Christian Bolenz, Maximilian Burger, Natalya Benderska-Söder & Bernd J. Schmitz-Dräger. (2022) Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria. Urologic Oncology: Seminars and Original Investigations.
Crossref
Crossref
Prashant Motiram Mulawkar, Gyanendra Sharma, Ashwin Tamhankar, Utsav Shah & Rickaz Raheem. (2022) Role of Macroscopic Image Enhancement in Diagnosis of Non-Muscle-Invasive Bladder Cancer: An Analytical Review. Frontiers in Surgery 9.
Crossref
Crossref
Ibrahim Jubber, Shahrokh F. Shariat, Samantha Conroy, Wei Shen Tan, Patrick C. Gordon, Yair Lotan, Edward M. Messing, Arnulf Stenzl, Bas van Rhijn, John D. Kelly, James W.F. Catto & Marcus G. Cumberbatch. (2020) Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. European Urology 77:5, pages 583-598.
Crossref
Crossref
Jean V. Joseph, Ralph Brasacchio, Chunkit Fung, Jay Reeder, Kevin Bylund, Deepak Sahasrabudhe, Shu Yuan Yeh, Ahmed Ghazi, Patrick Fultz, Deborah Rubens, Guan Wu, Eric Singer, Edward Schwarz, Supriya Mohile, James Mohler, Dan Theodorescu, Yi Fen Lee, Paul Okunieff, David McConkey, Hani Rashid, Chawnshang Chang, Yves Fradet, Khurshid Guru, Janet Kukreja, Gerald Sufrin, Yair Lotan, Howard Bailey, Katia Noyes, Seymour Schwartz, Kathy Rideout, Gennady Bratslavsky, Steven C. Campbell, Ithaar Derweesh, Per-Anders Abrahamsson, Mark Soloway, Leonard Gomella, Dragan Golijanin, Robert Svatek, Thomas Frye, Seth Lerner, Ganesh Palapattu, George Wilding, Michael Droller & Donald Trump. (2018) A Festschrift in Honor of Edward M. Messing, MD, FACS. Bladder Cancer 4:s1, pages S1-S43.
Crossref
Crossref
Oliver W. Hakenberg. 2018. Urinzytologie und Sedimentanalyse. Urinzytologie und Sedimentanalyse
135
152
.
Mihai Dorin Vartolomei & Shahrokh F. Shariat. 2018. Treating Urothelial Bladder Cancer. Treating Urothelial Bladder Cancer
101
112
.
Thomas A. Longo, Steven C. Brousell & Brant A. Inman. 2018. Precision Molecular Pathology of Bladder Cancer. Precision Molecular Pathology of Bladder Cancer
137
155
.
N. Löbig, F. Wezel, T. Martini, B. Schröppel & C. Bolenz. (2017) MikrohämaturieMicroscopic hematuria. Der Urologe 56:9, pages 1139-1146.
Crossref
Crossref
Bernd J. Schmitz-Dräger, Eva C. Kuckuck, Tahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Amanda Saltzman, Abhishek Srivastava, M’Liss A. Hudson, Roland Seiler, Tilmann Todenhöfer, Antonia Vlahou, H. Barton Grossman, Mark P. Schoenberg, Marta Sanchez-Carbayo, Lenuta-A. Brünn, Bas W.G. van Rhijn, Peter J. Goebell, Ashish M. Kamat, Morgan Roupret, Sharokh F. Shariat & Lambertus A. Kiemeney. (2016) Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelines. Urologic Oncology: Seminars and Original Investigations 34:10, pages 437-451.
Crossref
Crossref
Oyebode A. Taiwo, Martin D. Slade, Linda F. Cantley, Baylah Tessier-Sherman, Deron Galusha, Sharon R. Kirsche, A. Michael Donoghue & Mark R. Cullen. (2015) Bladder Cancer Screening in Aluminum Smelter Workers. Journal of Occupational & Environmental Medicine 57:4, pages 421-427.
Crossref
Crossref
Laura-Maria Krabbe, Robert S. Svatek, Shahrokh F. Shariat, Edward Messing & Yair Lotan. (2015) Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. Urologic Oncology: Seminars and Original Investigations 33:2, pages 65.e19-65.e25.
Crossref
Crossref
Bernd J. Schmitz-Dräger, Michael Droller, Vinata B. Lokeshwar, Yair Lotan, M''Liss A. Hudson, Bas W. van Rhijn, Michael J. Marberger, Yves Fradet, George P. Hemstreet, Per-Uno Malmstrom, Osamu Ogawa, Pierre I. Karakiewicz & Shahrokh F. Shariat. (2015) Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus. Urologia Internationalis 94:1, pages 1-24.
Crossref
Crossref
Nirmala Pillalamarri, Dara Shalom, Sharlene Sanidad, Meredith Akerman, Lawrence Lind & Harvey Winkler. (2014) The prevalence of microscopic hematuria in a cohort of women with pelvic organ prolapse. International Urogynecology Journal 26:1, pages 85-90.
Crossref
Crossref
Matthew T. HellerMitchell E. Tublin. (2014) In Search of a Consensus: Evaluation of the Patient With Hematuria in an Era of Cost Containment. American Journal of Roentgenology 202:6, pages 1179-1186.
Crossref
Crossref
Stéphane Larré, James W.F. Catto, Michael S. Cookson, Edward M. Messing, Shahrokh F. Shariat, Mark S. Soloway, Robert S. Svatek, Yair Lotan, Alexandre R. Zlotta & H. Barton Grossman. (2013) Screening for Bladder Cancer: Rationale, Limitations, Whom to Target, and Perspectives. European Urology 63:6, pages 1049-1058.
Crossref
Crossref
Rodney Davis, J. Stephen Jones, Daniel A. Barocas, Erik P. Castle, Erich K. Lang, Raymond J. Leveillee, Edward M. Messing, Scott D. Miller, Andrew C. Peterson, Thomas M.T. Turk & William Weitzel. (2012) Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline. Journal of Urology 188:6S, pages 2473-2481.
Crossref
Crossref
Robert S. Svatek & Yair Lotan. 2010. Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy, and Prognosis
196
209
.
Oliver W. Hakenberg. (2009) Re: Bladder Cancer Screening in a High Risk Asymptomatic Population Using a Point of Care Urine Based Protein Tumour Marker. European Urology 56:6, pages 1087-1088.
Crossref
Crossref
Yair Lotan, Keren Elias, Robert S. Svatek, Aditya Bagrodia, Geoffrey Nuss, Brett Moran & Arthur I. Sagalowsky. (2009) Bladder Cancer Screening in a High Risk Asymptomatic Population Using a Point of Care Urine Based Protein Tumor Marker. Journal of Urology 182:1, pages 52-58.
Crossref
Crossref
Herman Fernando, Sreenivasa S Thota, Glyn Burtt, Nicholas Waterfall & Imtiaz Husain. (2007) Importance of red patches diagnosed in cystoscopy for haematuria and lower urinary tract symptoms. Postgraduate Medical Journal 83:975, pages 62-63.
Crossref
Crossref
. (2006) Current World Literature. Current Opinion in Urology 16:5, pages 382-389.
Crossref
Crossref